Accessibility Menu
R1 Rcm logo

R1 Rcm(NASDAQ) RCM

This security has been delisted. This page is retained for historical reference.

R1 Rcm last closing stock price
MetricPriceDate
Last closeUSD 14.312024-11-18
R1 Rcm stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.14%USD 14.292024-11-11
1 month+0.42%USD 14.252024-10-18
3 month+2.07%USD 14.022024-08-20
Year to date+35.38%USD 10.572023-12-29
1 year+34.11%USD 10.672023-11-17
3 year-43.21%USD 25.202021-11-19
5 year+14.11%USD 12.542019-11-20
Since inception+5.61%USD 13.552010-05-20

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

RCM Financials

Key Financial Metrics (TTM)

Gross Margin

21.49%

Operating Margin

6.56%

Net Income Margin

0.15%

Return on Equity

0.12%

Return on Capital

3.29%

Return on Assets

0.07%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$472.10M

Operating Income

$136.30M

EBITDA

$415.50M

Operating Cash Flow

$291.40M

Capital Expenditure

-$105.00M

Free Cash Flow

$186.40M

Cash & ST Invst.

$167.30M

Total Debt

$2.31B

R1 Rcm Performance Analysis

R1 Rcm annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 1,474,600,000N/A
20222022-12-31USD 1,806,400,00022.5%
20232023-12-31USD 2,254,200,00024.8%
R1 Rcm sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-310.4%
Q12024-03-315.0%
Q22024-06-304.0%
Q32024-09-304.6%
R1 Rcm annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -1.90N/A
20222022-12-31USD -0.18-90.5%
20232023-12-31USD 0.01N/A
R1 Rcm sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-3110.7%
Q12024-03-31-2793.5%
Q22024-06-3078.4%
Q32024-09-30-161.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$656.80M

+14.7%

Gross Profit

$111.30M

-11.2%

Gross Margin

16.95%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

29,400

N/A

Net Income

-$19.90M

-1630.8%

EBITDA

$98.30M

-12.2%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$167.30M

+1.5%

Total Debt

$2.31B

+27.5%

Accounts Receivable

$484.60M

+33.9%

Inventory

$0.00

N/A

Long Term Debt

$2.22B

+28.3%

Short Term Debt

$118.20M

+12.6%

Return on Assets

0.07%

N/A

Return on Invested Capital

3.21%

N/A

Free Cash Flow

$60.30M

-21.5%

Operating Cash Flow

$89.10M

-18.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RETAReata Pharmaceuticals, Inc.
$172.36+0.02%
ISEEIVERIC bio, Inc.
$39.95+0.38%
LHCGLHC Group, Inc.
$169.81+0.00%
NARIInari Medical, Inc.
$79.97+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.